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Summary
Background:  Pigmented  villo-nodular  synovitis  (PVNS)  is  an  uncommon  proliferative  condition  of
the synovial  membrane  that  chieﬂy  affects  the  knee.  Arthroscopic  synovectomy  may  carry  lower
morbidity rates  but  higher  recurrence  rates  than  open  synovectomy.  Here,  our  objective  was
to evaluate  recurrence  rates  and  functional  outcomes  after  primary  arthroscopic  synovectomy
for PVNS  of  the  knee.
Hypothesis:  Primary  arthroscopic  synovectomy  preserves  knee  function  while  producing  low
recurrence  and  complication  rates.
Materials  and  methods:  We  retrospectively  included  consecutive  patients  with  histologically
documented  PVNS  managed  with  primary  arthroscopic  synovectomy  at  two  centres  between
1998 and  2011.  Twenty-three  patients,  13  men  and  10  women  with  a  mean  age  of  41  ±  12  years,
were reviewed  including  16  patients  with  nodular  and  7  with  diffuse  form  of  this  disease.
Patients  with  localized  disease  underwent  partial  synovectomy  and  those  with  diffuse  disease
complete synovectomy  followed  by  chemical  synovectomy  of  any  residual  lesions.  The  primary
outcome measure  was  recurrence.  Secondary  outcome  measures  were  the  Tegner-Lysholm  and
Ogilvie-Harris  scores.
Results:  Follow-up  data  were  obtained  after  a  mean  of  7  ±  4  years  in  21  patients  (14  with  nodu-
lar and  7  with  diffuse  disease),  of  whom  2  had  recurrences,  after  2  and  5  years,  respectively.
∗ Corresponding author.
E-mail addresses: aureganjc@yahoo.fr, jean-charles.auregan@abc.aphp.fr (J.C. Aurégan).
1877-0568/$ – see front matter © 2013 Elsevier Masson SAS. All rights reserved.
http://dx.doi.org/10.1016/j.otsr.2013.08.004
938  J.C.  Aurégan  et  al.
At  last  follow-up,  neither  patient  had  any  evidence  of  recurrence.  The  mean  Tegner-Lysholm
score was  signiﬁcantly  improved  (from  68  ±  10  to  90  ±  8,  P  =  0.0004)  and  the  mean  Ogilvie-Harris
score indicated  excellent  function  (11  ±  1).
Discussion:  Primary  arthroscopic  synovectomy  ensures  satisfactory  control  of  PVNS  while  pre-
serving knee  function.  A  full  recovery  remains  possible  even  in  patients  with  diffuse  disease.  In
the event  of  a  recurrence,  open  synovectomy  can  be  performed.
Level of  evidence:  Level  IV,  retrospective  study  of  consecutive  patients.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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tinely.  Posterior  synovectomy  in  patients  with  diffusentroduction
igmented  villo-nodular  synovitis  (PVNS)  is  an  idiopathic
enign  proliferative  disorder  of  the  synovial  membrane  with
n  estimated  incidence  of  1.8/106 population  [1].  Although
o  age  group  is  exempt,  younger  patients  seem  predomi-
antly  affected,  with  no  difference  between  genders  [1].
he  knee  is  the  main  site  of  involvement  [2,3]  but  any  joint
an  be  affected  [4].  Untreated  PVNS  rapidly  results  in  irre-
ersible  joint  destruction.
In  1976,  Granowitz  et  al.  [5]  distinguished  two  variants
f  PVNS  based  on  whether  the  intra-articular  lesions  were
ocalised  (nodular  PVNS)  or  affected  the  entire  synovium
diffuse  PVNS).  Extra-articular  extension  of  the  lesions  to
he  adjacent  muscles  and  tendons  can  occur,  chieﬂy  in  dif-
use  forms  [6].
Complete  surgical  excision  of  all  the  lesions  is  the
tandard  treatment  for  PVNS  [7].  The  surgical  modalities
re  poorly  standardised,  however,  as  the  low  incidence  of
VNS  precludes  large  treatment  trials.  In  general,  open  total
ynovectomy  is  preferred  in  diffuse  PVNS  [8]  and  arthro-
copic  synovectomy  is  reserved  for  localised  nodular  PVNS
9,10].  Compared  to  open  synovectomy,  arthroscopic  syn-
vectomy  may  ensure  better  preservation  of  knee  function
hile  producing  acceptable  local  recurrence  rates  and  few
omplications  [10,11].  Both  the  local  recurrence  rate  and
nee  function  recovery  have  been  reported  to  vary  with  the
xtent  of  the  lesions  [12].  Nevertheless,  PVNS  is  probably
 continuum  with  no  clear-cut  separation  between  nodu-
ar  and  diffuse  forms.  The  better  functional  outcomes  with
rthroscopy  compared  to  open  surgery  constitute  a  rationale
or  broadening  the  indications  of  arthroscopic  treatment.
Here,  our  main  objective  was  to  evaluate  outcomes  after
rimary  arthroscopic  synovectomy  for  nodular  or  diffuse
VNS.  Our  study  hypothesis  was  that  primary  arthroscopic
ynovectomy  would  preserve  knee  function  while  producing
ow  recurrence  and  complication  rates.
aterial and methods
e  conducted  a  retrospective  study  in  two  centres  special-
zed  in  arthroscopic  surgery  of  the  knee.  In  both  centres,  all
atients  with  PVNS  of  the  knee  were  managed  with  primary
rthroscopic  synovectomy.atient  selection
ll  patients  managed  with  arthroscopic  synovectomy  for  his-
ologically  documented  PVNS  of  the  knee  between  1998
d
f
T
nnd  2011  were  eligible,  including  those  with  recurrent  PVNS
fter  arthroscopic  synovectomy.  We  did  not  include  patients
ith  extra-articular  lesions  and/or  a  history  of  open  syn-
vectomy  of  the  same  knee  and/or  recurrent  PVNS  after
pen  surgery  at  the  same  knee.
During  the  study  period,  28  patients  underwent  surgery
n  either  centre  for  PVNS  of  the  knee  (Fig.  1).  Among  them,
 had  superﬁcial  lesions  extending  extra-articularly  and
ere  managed  with  open  surgery.  Of  the  26  arthroscopically
reated  patients,  3  had  recurrent  diffuse  PVNS  after  pri-
ary  open  synovectomy  performed  elsewhere  and  were
herefore  not  included  in  our  study.  Of  the  23  included
atients,  7  had  diffuse  and  16  nodular  disease.  There  were
3  men  and  10  women  with  a  mean  age  of  41  ±  12  years.
mong  these  23  patients,  3  had  recurrent  PVNS,  includ-
ng  1  after  partial  arthroscopic  synovectomy  for  nodular
isease  and  2  after  incomplete  arthroscopic  synovectomy
or  diffuse  disease.  Mean  maximum  knee  ﬂexion  was
26  ±  12◦.
Magnetic  resonance  imaging  (MRI)  was  performed  in
2  of  the  23  patients  (Figs.  2  and  3).  Changes  suggesting
VNS  were  recorded  including  thickening  and  heterogeneity
f  the  synovial  membrane  with  post-gadolinium  enhance-
ent  and  low-signal  foci  consistent  with  hemosiderin
eposits  within  the  joint  [13]. The  ﬁndings  indicated  def-
nite  PVNS  in  14  patients  and  possible  PVNS  in  6  patients,
hereas  2  patients  had  no  suggestive  MRI  features.  MRI
lso  served  to  assess  the  extent  of  the  synovial  lesions.
n  1  patient,  a  metallic  foreign  body  precluded  MRI
nd  computed  arthrotomography  was  performed  instead:
o  changes  suggesting  PVNS  were  found.  The  diagno-
is  was  conﬁrmed  postoperatively  in  all  23  patients  by
istological  examination  of  the  synovial  membrane  speci-
en.
urgical  technique
he  23  procedures  were  performed  by  3  senior  surgeons.
 30◦ arthroscope  was  used.  A  synovial  membrane  biopsy
as  obtained  routinely.  Synovectomy  was  achieved  using
 motorised  shaver  with  a  5.5-mm  blade  and  the  three
tandard  portals  (antero-medial,  antero-lateral,  and  supero-
ateral).  In  patients  with  nodular  lesions  conﬁned  to  the
nterior  knee,  the  posterior  knee  was  not  explored  rou-isease  (Fig.  4) or  posterior  nodular  disease  (Fig.  5) was  per-
ormed  via  the  postero-medial  and  postero-lateral  portals.
he  postero-medial  approach  was  achieved  by  transillumi-
ation  [9].
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RFigure  1  Patient  ﬂow  chart  (PVNS  =  pigmented  vill
Postoperative  chemical  synovectomy
In  patients  with  diffuse  PVNS,  the  joint  cavity  was  care-
fully  explored  after  total  synovectomy  to  assess  the  risk
of  residual  lesions.  When  the  risk  was  deemed  non-
existent,  no  additional  treatment  was  given.  Otherwise,
chemical  synovectomy  was  performed  3  to  6  months  after
the  arthroscopic  procedure.  Osmic  acid  was  used  until
2007,  when  the  French  drug  safety  agency  withdrew  this
compound,  and  triamcinolone  hexacetonide  (Hexatrione®)
thereafter.
Postoperative  management
A  drain  was  placed  routinely  in  the  joint  cavity  then  removed
after  24  to  72  hours.  Passive  and  active  rehabilitation  ther-
apy  was  started  on  the  ﬁrst  postoperative  day  and  continued
for  1  month.  A  knee-extension  splint  was  worn  between  the
rehabilitation  sessions  for  1  month  to  avoid  ﬂexion  contrac-
ture.  Patients  were  re-evaluated  after  1,  3,  6,  and  12  months
then  once  a  year.  MRI  with  gadolinium  injection  was  per-
formed  after  1  year.  For  this  study,  all  patients  were  asked
to  come  in  for  re-evaluation.
Outcome  measures
The  primary  evaluation  criterion  was  the  rate  of  local  recur-
rence  at  last  follow-up.  Local  recurrence  was  suspected
based  on  the  clinical  and  or  MRI  ﬁndings  then  conﬁrmed
histologically.Secondary  outcome  measures  were  the  scores  at  last
follow-up  on  two  knee-function  scales,  the  Tegner-Lysholm
Knee  Scoring  Scale  for  general  knee  function  [14]  and  the
Ogilvie-Harris  scale  developed  speciﬁcally  for  PVNS  [12].
M
2
ldular  synovitis;  MRI  =  magnetic  resonance  imaging).
egner-Lysholm  score  categories  were  0—64,  poor;  65—83,
air;  and  84—100,  excellent.  Ogilvie-Harris  scores  were  cat-
gorized  as  follows:  0—3,  poor;  4—6,  fair;  7—9,  good;  and
0—12,  excellent.
tatistical  analysis
TATA.10  (StataCorp,  College  Station,  TX,  USA)  was  used
or  the  statistical  analyses.  Given  the  small  sample  size,
e  chose  non-parametric  tests.  Quantitative  variables  were
ompared  using  the  Mann-Whitney  test  or  Wilcoxon  test  for
aired  data.  Values  of  P  smaller  than  0.05  were  considered
igniﬁcant.
esults
f  the  23  patients,  2  were  lost  to  follow-up,  after  2  months
nd  13  years,  respectively.  Both  had  nodular  disease  and
either  experienced  recurrences.  These  2  patients  were
xcluded  from  the  analyses.  Mean  follow-up  in  the  remaining
1  patients  was  7  ±  4  years.
omplications
 25-year-old  woman  with  diffuse  PVNS  managed  by
otal  arthroscopic  synovectomy  experienced  postoperative
aemarthrosis.  Surgical  drainage  of  the  joint  was  required
 month  after  surgery.
ecurrence  rateRI  was  performed  1  year  postoperatively  in  17  of  the
3  patients  and  showed  no  signs  of  recurrence.  Neverthe-
ess,  histologically  documented  recurrences  developed  in
940  J.C.  Aurégan  et  al.
Figure  2  Magnetic  resonance  imaging  in  a  patient  with  nodular  pigmented  villo-nodular  synovitis  of  the  knee.  a:  coronal  section,
T2 fast  spin-echo  Fat-Sat  sequence:  well-delineated  intra-articular  ovoid  mass  overhanging  the  anterior  inter-meniscal  ligament  on
the midline,  generating  higher  signal  than  the  surrounding  tissue,  and  surrounded  by  a  low-signal  shell;  b:  sagittal  section,  T2  fast
spin-echo Fat-Sat  sequence:  mass  in  contact  with  Hoffa’s  triangle,  with  no  evidence  of  inﬁltration.  Markedly  low  signal  from  the
shell. Heterogeneous  content,  with  relative  high  signal  contrasting  with  low-signal  foci.  No  joint  effusion;  c:  axial  section,  T2  fast
spin-echo Fat-Sat  sequence:  the  mass  is  located  on  the  midline;  d:  sagittal  section,  T1  sequence:  ovoid  mass  anterior  to  the  insertion
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mf the  anterior  cruciate  ligament,  from  which  it  is  clearly  sepa
ignal relative  to  the  gastrocnemius  muscle  and  is  surrounded  b
 patients,  both  with  diffuse  disease.  A  41-year-old  man
ith  diffuse  PVNS  of  the  right  knee  initially  treated  with
otal  arthroscopic  synovectomy  followed  3 months  later  by
hemical  synovectomy  had  normal  MRI  ﬁndings  after  1  year
ut  was  diagnosed  with  a  recurrence  5  years  after  the
rthroscopic  procedure.  He  was  managed  with  open  total
ynovectomy  and  had  no  evidence  of  recurrence  3  years
ater.  The  other  patient  was  a  27-year-old  man  with  diffuse
VNS  of  the  left  knee.  He  underwent  incomplete  arthro-
copic  synovectomy  at  another  centre  then  experienced  a
ecurrence  managed  with  arthroscopic  total  synovectomy
t  one  of  the  study  centres.  The  risk  of  residual  lesions  was
eemed  non-existent  and  chemical  synovectomy  was  there-
ore  not  performed.  A  recurrence  was  diagnosed  2  years
ater  and  managed  with  arthroscopic  total  synovectomy.
t  last  follow-up  6  months  later,  he  had  no  signs  of  recur-
ence.
a
n
P
od.  The  mass  is  sharply  marginated.  Its  content  generates  high
ow-signal  shell.
Repeat  arthroscopy  was  performed  in  2  patients  with  per-
istent  pain  suggesting  a  recurrence  despite  the  absence  of
RI  abnormalities.  The  gross  and  histological  features  of  the
ynovial  membrane  ruled  out  a  recurrence.
unctional  outcomes
he  mean  Tegner-Lysholm  score  improved  signiﬁcantly
rom  68  ±  10  pre-operatively  to  90  ±  8  at  last  follow-up
P  =  0.0004).  Mean  values  at  last  follow-up  were  not  signiﬁ-
antly  different  between  the  groups  with  diffuse  and  nodular
isease  (90  ±  7  and  90  ±  10,  respectively,  P  =  0.91).  The
ean  Ogilvie-Harris  score  at  last  follow-up  was  11  ±  1  over-
ll,  with  no  signiﬁcant  difference  between  the  groups  with
odular  and  diffuse  disease  (11  ±  1  and  10  ±  1,  respectively;
 =  0.53).  Both  score  values  indicated  excellent  functional
utcomes  at  last  follow-up.
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Figure  3  Magnetic  resonance  imaging  in  a  patient  with  diffuse  villo-nodular  synovitis  of  the  knee.  T1-sequence  before  (a)  and
after (b)  injection.  Diffuse  thickening  and  enhancement  of  the  anterior  and  posterior  synovial  membrane.  Joint  effusion.
Figure  4  Arthroscopic  appearance  of  diffuse  pigmented  villo-nodular  synovitis  of  the  knee.  The  arthroscope  has  been  inserted
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ovia the  antero-lateral  portal  and  the  quadricipital  recess  is  bein
typical appearance  of  thick  tan-coloured  villi  with  pinpoint  hae
Discussion
This  study  shows  that  primary  arthroscopic  synovectomy  for
PVNS  of  the  knee  is  associated  with  few  complications  and
produces  an  overall  low  recurrence  rate  while  preserving
knee  function.
Whereas  nodular  PVNS  is  associated  with  few  or  no
recurrences  [10,15],  diffuse  PVNS  can  recur  regardless  of
the  treatment  modality  used  [16].  In  our  study,  none  of  the
patients  with  nodular  disease  experienced  recurrences,  in
keeping  with  ﬁndings  from  two  other  case-series  studies
[10,15].  In  contrast,  in  a  study  of  20  patients  with  nodu-
lar  PVNS,  4  (20%)  patients  had  recurrences  [17].  Recurrence
rates  after  open  synovectomy  for  nodular  PVNS  have  ranged
from  0%  [18]  to  15%  [19]  and  29%  [8].  In  our  patients  with
diffuse  disease,  the  29%  (2/7  patients)  recurrence  rate  is
consistent  with  recurrence  rates  reported  after  open  syn-
ovectomy  (25%  [20],  33%,  [21],  and  46%  [19]).  However,  one
group  reported  a  recurrence  rate  of  only  8%  [22].
t
r
aplored.  Villi  are  seen  to  line  the  entire  joint  surface.  Note  the
hagic  effusions.
Mean  functional  scores  in  our  study  were  excellent  in
oth  nodular  and  diffuse  disease.  No  signiﬁcant  difference
n  function  was  found  between  these  two  groups,  but  only
 patients  had  diffuse  lesions.  In  previous  studies,  func-
ional  outcomes  seemed  better  in  nodular  disease  and  varied
ith  the  treatment  modality.  In  a  study  of  20  patients  with
odular  PVNS  managed  with  arthroscopic  synovectomy,  the
edian  Tegner-Lysholm  score  at  last  follow-up  indicated
xcellent  function  (85.5;  range,  83—88)  [17]. In  25  patients
anaged  arthroscopically  for  diffuse  (n  =  20)  or  nodular
n  =  5)  PVNS,  the  mean  postoperative  Ogilvie-Harris  score
as  11.3  (excellent)  after  nodule  excision,  7.8  (good)  after
artial  synovectomy,  and  9.3  (good)  after  total  synovectomy
12]. In  contrast  to  arthroscopic  surgery,  open  surgery  is
ften  associated  with  range-of-motion  limitation  (24%  [22]
o  50%  [21]  of  patients).
Thus,  routine  primary  arthroscopic  synovectomy  allows
emoval  of  the  largest  possible  number  of  lesions  while  prob-
bly  providing  better  function  than  open  surgery  and  also
942  J.C.  Aurégan  et  al.
Figure  5  Arthroscopic  appearance  of  nodular  pigmented  villo-nodular  synovitis  of  the  knee.  The  arthroscope  has  been  inserted
via the  antero-lateral  portal.  The  nodule  ﬁlls  the  intercondylar  notch  and  exhibits  the  typical  tan  colour.  Note  the  anterior  cruciate
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cigament behind  the  nodule.  The  nodule  is  appended  from  a  we
f the  notch  is  considerably  lighter  in  colour,  contrasting  with  t
roducing  a  low  complication  rate.  However,  arthroscopic
ynovectomy  for  PVNS  is  a  highly  specialised  procedure  asso-
iated  with  a  long  and  arduous  learning  curve.
In  our  patients,  posterior  synovectomy  was  performed  via
he  standard  posterior  portals.  Another  option  consists  in  the
ack-and-forth  technique,  which  may  be  valuable  particu-
arly  in  patients  with  diffuse  lesions  [9,23].
Osmic  acid  was  used  for  chemical  synovectomy  until
007,  when  the  French  drug  safety  agency  withdrew
pproval  of  this  compound  based  on  an  unfavourable
isk/beneﬁt  assessment  [24].  Osmic  acid  is  no  longer  used
n  humans.  Alternatives  for  local  chemical  synovectomy  are
exatrione® and  radiopharmaceuticals  such  as  yttrium  (90Y)
itrate  and  yttrium  (90Y)  silicate.  External  beam  radiation
herapy  combined  with  total  synovectomy  may  provide  good
utcomes,  most  notably  in  patients  at  high  risk  for  recur-
ence  [25],  but  has  not  been  proven  effective  by  level-I
vidence.
Factors  associated  with  local  PVNS  recurrence  include
iffuse  disease,  involvement  of  a  large  joint,  incomplete
ynovectomy,  a  history  of  recurrence,  and  extra-articular
nvolvement  [6,8,20,26].  In  our  study,  both  patients  with
ecurrences  had  diffuse  disease  and  1  of  them  also  had  a
istory  of  prior  recurrence.  In  this  last  patient,  the  surgeon
c
f
l
icularised  pedicle.  c  and  d:  the  normal  synovium  lining  the  roof
ark  colour  of  the  nodule.
elt  the  second  procedure  had  removed  all  the  lesions  and
onsequently  did  not  prescribe  chemical  synovectomy.  The
umber  of  patients  with  recurrences  was  too  small  for  a  mul-
ivariate  analysis  aimed  at  identifying  factors  independently
ssociated  with  recurrences.
Our  study  has  several  limitations.  The  data  were  col-
ected  retrospectively,  but  nearly  all  the  patients  were
e-evaluated  speciﬁcally  for  the  study.  The  sample  size  was
mall,  in  keeping  with  the  low  incidence  of  PVNS.  Among
revious  studies,  few  included  more  than  23  patients  [8,20].
inally,  although  the  mean  follow-up  of  7  years  is  satisfac-
ory,  follow-up  in  some  patients  was  only  12  months,  limiting
he  validity  of  their  ﬁnal  outcome  assessments.
onclusion
rimary  arthroscopic  synovectomy,  either  partial  in  nodular
isease  or  total  in  diffuse  disease,  with  subsequent  chemi-
al  synovectomy  if  appropriate,  ensures  satisfactory  disease
ontrol  while  preserving  knee  function.  The  chances  for  a
ull  recovery  are  preserved  even  in  patients  with  diffuse
esions.  In  addition,  open  synovectomy  can  be  performed
n  the  event  of  a recurrence.
lar  sy
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